Which companies overlap with Centre for Endocrinology and Reproductive Medicine, Italy's portfolio?

Top competitors by shared drug class: Amgen, Assistance Publique - Hôpitaux de Paris, King's College London, Orasis Pharmaceuticals Ltd., Radboud University Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/centre-for-endocrinology-and-reproductive-medicine-italy.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Centre for Endocrinology and Reproductive Medicine, Italy — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Centre for Endocrinology and Reproductive Medicine, Italy pipeline: 3 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Aromatase inhibitor and GnRH analog	Aromatase inhibitor and GnRH analog	marketed
GM-CSF medium	GM-CSF medium	marketed
GnRH analog alone	GnRH analog alone	marketed
GM-CSF group	GM-CSF group	phase 3	Cytokine	GM-CSF receptor (CD116/CD131)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amgen · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
King's College London · 1 shared drug class
Orasis Pharmaceuticals Ltd. · 1 shared drug class
Radboud University Medical Center · 1 shared drug class
Sandoz · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Centre for Endocrinology and Reproductive Medicine, Italy:

Cite this brief

Drug Landscape (2026). Centre for Endocrinology and Reproductive Medicine, Italy — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/centre-for-endocrinology-and-reproductive-medicine-italy. Accessed 2026-05-18.